Syngene International Share Price

ABOUT Syngene International

• Industry Biotechnology & Drugs
• ISIN INE398R01022
• BSE Code 539268
• NSE Code SYNGENE

Syngene International Limited is an India-based integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The Company's services include discovery, development, manufacturing, SynVent Integrated Drug discovery, dedicated centers, and Center for Advanced Protein Studies (CAPS). Its discovery services span the entire spectrum of early-stage research from target identification to delivery of drug candidates for further development. It offers preclinical development, active pharmaceutical ingredient and drug product development for both small molecules and biologics. It has capabilities for current Good Manufacturing Practices (cGMP) manufacturing from benchtop volume to commercial scale. SynVent is its drug discovery platform for enabling fully integrated therapeutic drug discovery and development across small molecules, new modalities and biologics.

MANAGEMENT

• Peter Bains Chief Executive Officer, Managing Director, Additional Director
• Deepak Jain Chief Financial Officer
• Andrew Webster Chief Human Resources Officer
• Kenneth Barr Senior Vice President - Discovery Services
• Alex Del Priore Senior Vice President - Manufacturing Services
• Jayashree Aiyar Chief Scientific Officer
• Priyadarshini Mahapatra Head Legal, Company Secretary and Compliance Officer
• Pramuch Goel Head of Corporate Affairs
• Caroline Hempstead Head of Corporate Affairs
• Alok Mehrotra Chief Quality Officer